Market Cap | ₹12Cr |
ROE | 0.36% |
P/E Ratio(TTM) | 738.00 |
EPS(TTM) | 0.03 |
P/B Ratio | 2.64 |
Dividend Yield | 0.00% |
Industry P/E | 38.99 |
Book Value | 8.38 |
Debt to Equity | 0.01 |
Face Value | 10 |
Parent Organisation | Venmax Drugs & Pharmaceuticals Limited |
BSE Symbol | 531015 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Divi's Laboratories | NA (0.00%) | 65.50 | ||
Neuland Laboratories | NA (0.00%) | 101.64 | ||
Jubilant Pharmova | NA (0.00%) | 36.14 | ||
Acutaas Chemicals | NA (0.00%) | 58.44 |